A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

7,534

Participants

Timeline

Start Date

April 16, 2016

Primary Completion Date

June 28, 2023

Study Completion Date

June 28, 2023

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

Herpes Zoster Vaccine GSK1437173A

Intramuscular injection

Trial Locations (161)

112

GSK Investigational Site, Taipei

333

GSK Investigational Site, Tau-Yuan

2145

GSK Investigational Site, Westmead

2522

GSK Investigational Site, Wollongong

3220

GSK Investigational Site, Geelong

10002

GSK Investigational Site, Taipei

10629

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

11446

GSK Investigational Site, Stockholm

13347

GSK Investigational Site, Berlin

13619

GSK Investigational Site, Tallinn

15236

GSK Investigational Site, Pittsburgh

15401

GSK Investigational Site, Uniontown

16132

GSK Investigational Site, Genova

17491

GSK Investigational Site, Peralada Girona

19300

GSK Investigational Site, Rosiers-d'Égletons

20251

GSK Investigational Site, Hamburg

20520

GSK Investigational Site, Turku

20900

GSK Investigational Site, Monza MB

21045

GSK Investigational Site, Columbia

21075

GSK Investigational Site, Elkridge

22143

GSK Investigational Site, Hamburg

22415

GSK Investigational Site, Hamburg

23554

GSK Investigational Site, Lübeck

23606

GSK Investigational Site, Newport News

27103

GSK Investigational Site, Winston-Salem

27518

GSK Investigational Site, Cary

28040

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

28100

GSK Investigational Site, Pori

28144

GSK Investigational Site, Salisbury

28209

GSK Investigational Site, Charlotte

28222

GSK Investigational Site, Madrid

28412

GSK Investigational Site, Wilmington

28500

GSK Investigational Site, Barcelona

28601

GSK Investigational Site, Hickory

29464

GSK Investigational Site, Mt. Pleasant

29651

GSK Investigational Site, Greer

31600

GSK Investigational Site, Muret

33100

GSK Investigational Site, Tampere

34000

GSK Investigational Site, Durango

37100

GSK Investigational Site, Tours

37620

GSK Investigational Site, Bristol

39112

GSK Investigational Site, Magdeburg

40447

GSK Investigational Site, Taichung

43460

GSK Investigational Site, Alcover Tarragona

44122

GSK Investigational Site, Beachwood

44281

GSK Investigational Site, Wadsworth

44300

GSK Investigational Site, Nantes

45190

GSK Investigational Site, Zapopan Jalisco

45355

GSK Investigational Site, Essen

45359

GSK Investigational Site, Essen

46020

GSK Investigational Site, Valencia

47574

GSK Investigational Site, Goch

49000

GSK Investigational Site, Angers

49100

GSK Investigational Site, Angers

49110

GSK Investigational Site, Montrevault

49500

GSK Investigational Site, Segré

49610

GSK Investigational Site, Mûrs-Erigné

50106

GSK Investigational Site, Tartu

51069

GSK Investigational Site, Cologne

53000

GSK Investigational Site, Laval

53200

GSK Investigational Site, Château-Gontier

55116

GSK Investigational Site, Mainz

55624

GSK Investigational Site, Rhaunen

58455

GSK Investigational Site, Witten

60100

GSK Investigational Site, Seinäjoki

63003

GSK Investigational Site, Clermont-Ferrand

65439

GSK Investigational Site, Flörsheim

66013

GSK Investigational Site, Chieti

67100

GSK Investigational Site, Kokkola

67207

GSK Investigational Site, Wichita

68161

GSK Investigational Site, Mannheim

69469

GSK Investigational Site, Weinheim

72074

GSK Investigational Site, Tübingen

74363

GSK Investigational Site, Güglingen

78229

GSK Investigational Site, San Antonio

80339

GSK Investigational Site, München

83712

GSK Investigational Site, Boise

84123

GSK Investigational Site, Murray

85018

GSK Investigational Site, Phoenix

85020

GSK Investigational Site, Phoenix

85213

GSK Investigational Site, Mesa

85221

GSK Investigational Site, Dachau

85306

GSK Investigational Site, Glendale

88239

GSK Investigational Site, Wangen

90220

GSK Investigational Site, Oulu

91126

GSK Investigational Site, Rednitzhembach

91978

GSK Investigational Site, Spring Valley

94550

GSK Investigational Site, Künzing

94574

GSK Investigational Site, Wallerfing

97070

GSK Investigational Site, Würzburg

30150-320

GSK Investigational Site, Belo Horizonte

80069-900

GSK Investigational Site, Curitiba

80240-000

GSK Investigational Site, CuritibaPR

04266-010

GSK Investigational Site, São Paulo

04312903

GSK Investigational Site, São Paulo

J8Y1W2

GSK Investigational Site, Gatineau

B3K 6R8

GSK Investigational Site, Halifax

J7J 2K8

GSK Investigational Site, Montreal

H9R 4S3

GSK Investigational Site, Pointe-Claire

G1E 7G9

GSK Investigational Site, Québec

G1W 4R4

GSK Investigational Site, Québec

J1J 2G2

GSK Investigational Site, Sherbrooke

M4S 1Y2

GSK Investigational Site, Toronto

M9W 4L6

GSK Investigational Site, Toronto

B2N 1L2

GSK Investigational Site, Truro

V5Z 1M9

GSK Investigational Site, Vancouver

V8V 3M9

GSK Investigational Site, Victoria

N4V 0E1

GSK Investigational Site, Woodstock

612 00

GSK Investigational Site, Brno

370 05

GSK Investigational Site, České Budějovice

500 05

GSK Investigational Site, Hradec Králové

02230

GSK Investigational Site, Espoo

00100

GSK Investigational Site, Helsinki

00930

GSK Investigational Site, Helsinki

04400

GSK Investigational Site, Järvenpää

01097

GSK Investigational Site, Dresden

09599

GSK Investigational Site, Freiberg

06366

GSK Investigational Site, Köthen

04315

GSK Investigational Site, Leipzig

Unknown

GSK Investigational Site, Kwun Tong Kowloon

000000

GSK Investigational Site, Shatin

00163

GSK Investigational Site, Roma

07100

GSK Investigational Site, Sassari

810-0021

GSK Investigational Site, Fukuoka

812-0025

GSK Investigational Site, Fukuoka

813-8588

GSK Investigational Site, Fukuoka

816-0864

GSK Investigational Site, Fukuoka

224-8503

GSK Investigational Site, Kanagawa

247-8533

GSK Investigational Site, Kanagawa

142-0054

GSK Investigational Site, Tokyo

142-8666

GSK Investigational Site, Tokyo

154-0024

GSK Investigational Site, Tokyo

425-707

GSK Investigational Site, Ansan

420-767

GSK Investigational Site, Bucheon-si Kyunggi-do 14584

400-711

GSK Investigational Site, Incheon

220-701

GSK Investigational Site, Kangwon-do

150-950

GSK Investigational Site, Seoul

152-703

GSK Investigational Site, Seoul

08025

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

08430

GSK Investigational Site, Barcelona

08540

GSK Investigational Site, Barcelona

08550

GSK Investigational Site, Hostalets de Balenya Ba

SE-506 30

GSK Investigational Site, Borås

SE-631 88

GSK Investigational Site, Eskilstuna

SE-413 45

GSK Investigational Site, Gothenburg

SE-551 85

GSK Investigational Site, Jönköping

SE-371 79

GSK Investigational Site, Karlskrona

SE-58758

GSK Investigational Site, Linköping

SE-211 52

GSK Investigational Site, Malmo

SE-703 62

GSK Investigational Site, Örebro

SE-751 85

GSK Investigational Site, Uppsala

SE-194 61

GSK Investigational Site, Vällingby

CV9 1EU

GSK Investigational Site, Atherstone Warwickshire

BT7 2EB

GSK Investigational Site, Belfast

BA15 1DQ

GSK Investigational Site, Bradford on Avon Wiltsh

BT42 4JP

GSK Investigational Site, Broughshane

PR7 7NA

GSK Investigational Site, Chorley

L22 0LG

GSK Investigational Site, Liverpool

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02723773 - A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults | Biotech Hunter | Biotech Hunter